---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-021926"
form_type: "8-K"
ticker: "INFU"
cik: "0001337013"
company_name: "InfuSystem Holdings, Inc"
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T05:12:25.863207+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# InfuSystem reports Q1 revenue up 5% to $32.0M; net loss widens, reaffirms guidance

## Summary
- Net revenues of $32.0M (+5% YoY); record quarterly revenue.
- Gross margin improved to 51.5% from 49.2%; gross profit +10%.
- Net loss widened to $1.1M ($0.05/share) from $0.3M ($0.02) a year ago.
- Adjusted EBITDA fell 9% to $3.9M, with margin of 12.1% vs 13.9%.
- FY 2024 guidance reaffirmed: high-single-digit revenue growth, high-teens EBITDA margin.

## SEC filing metadata
- accession: 0001628280-24-021926
- form_type: 8-K
- ticker: INFU
- cik: 0001337013
- company_name: InfuSystem Holdings, Inc
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1337013/000162828024021926/0001628280-24-021926-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1337013/000162828024021926/infu-20240509.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-021926
- JSON: https://secwatch.observer/filing/0001628280-24-021926.json
- Plain text: https://secwatch.observer/filing/0001628280-24-021926.txt

## Key facts
- Earnings Releases
  InfuSystem Holdings, Inc reported first quarter ended March 31, 2024 results: revenue Net revenues totaled $32.0 million, net income Net loss was $1.1 million, EPS $(0.05) per diluted share.
  - Period: first quarter ended March 31, 2024
  - Revenue: Net revenues totaled $32.0 million
  - Net income: Net loss was $1.1 million
  - EPS: $(0.05) per diluted share
  - Result: reported results
  source text: • Net revenues totaled $32.0 million, an increase of 5% vs. prior year. ◦ Patient Services net revenue was $18.6 million, a decrease of 1% vs. prior year. ◦ Device Solutions net revenue was $13.4 million, an increase of 16% vs. prior year. • Gross profit was $16.5 million, an increase of 10% vs. prior year. • Gross margin was 51.5%, an increase of 2.3% vs. prior year. ◦ Patient Services gross margin was 66.0%, an increase of 4.5% vs. prior year. ◦ Device Solutions gross margin was 31.3%, an increase of 1.9% vs. prior year. • Net loss was $1.1 million, or $(0.05) per diluted share vs. prior year net loss of $0.3 million, or $(0.02) per diluted share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1337013/000162828024021926/0001628280-24-021926-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.